April 25, 2025

FDA Approves Penpulimab-kcqx for NPC

The FDA approved penpulimab-kcqx for first line and previously treated recurrent or metastatic non-keratinizing nasopharyngeal carcinoma.

Conexiant

April 24, 2025

Vitamin D Multifaceted CRC Immunomodulator Revealed

"Vitamin D enhances immune organ functions such as the spleen and lymph nodes, and boosts T-cell activity, which is essential in defending the body against tumors."

Conexiant

April 23, 2025

Sense of Belonging 'Critical' for Workplace Retention

Individuals who reported a neutral level of satisfaction with their sense of belonging were approximately 3 times more likely to express an intent to leave, while those who were dissatisfied were 7 times more likely to do so, compared to individuals who were satisfied with their sense of belonging.

Conexiant

April 04, 2025

First IgG4-RD Treatment Approved

A humanized monoclonal antibody that targets CD19+ B cells is first FDA-approved treatment for immunoglobulin G4–related disease, reducing flare risk and glucocorticoid use in clinical trials.

Conexiant

April 03, 2025

New Option for IgA Nephropathy Management

The FDA has granted accelerated approval to Vanrafia (atrasentan) for reducing proteinuria in adults with primary immunoglobulin A nephropathy who are at risk of rapid disease progression.

Conexiant

April 01, 2025

Cemiplimab Effective for Advanced cSCC

Meta-analysis of 19 studies reveals promising 54.5% objective response rate and manageable safety profile for PD-1 inhibitor in treating advanced cutaneous squamous cell carcinoma.

Conexiant

March 07, 2025

What's Your Diagnosis? Persistent Sore Throat and Lymphadenopathy in a 67-Year-Old Man

A 67-year-old man's secondary syphilis was diagnosed nearly a year after presenting with persistent sore throat and swollen lymph nodes.

Conexiant

February 05, 2025

Enlarging Painless Nodule Destroying Nail: What's Your Diagnosis?

A painless finger nodule leads to nail destruction, revealing an uncommon but locally aggressive tumor of the tendon sheath.

Conexiant

January 22, 2025

Thyroidectomy IONM: Usage Up, Benefits Modest

"Although IONM during thyroidectomy is common in the US, these results suggest that further research is needed to identify patients who would benefit the most from this technology."

Conexiant